JLB's EIC in the News - Clinical research on opioid use in HIV-infected people

JLB's EIC in the news: Wistar receives over $12M for clinical research on opioid use in HIV-infected people

PHILADELPHIA -- (September 24, 2019) -- The Wistar Institute was awarded two major grants totaling more than $12 million from the National Institute on Drug Abuse (NIDA), part of the National Institutes of Health, to fund an international multidisciplinary clinical research consortium spearheaded by Wistar's HIV Research Program. The consortium, including several partner institutions in the U.S. and abroad, will investigate the impact of opioid use disorder (OUD) and medications for opioid use disorder (MOUDs) on immune recovery in response to antiretroviral therapy (ART) in HIV-infected people. Read more...